Our client writes for First Voice Magazine on GDPR
Client News 
CAN THIRD PARTY SERVICE PROVIDERS BE FINED FOR THE PRIVACY LAPSES?
Client NewsOur client writes for Startups Magazine on GDPR fines
Nobel laureate Tasuku Honjo loses multi-billion dollar patent dispute
Client NewsOur client comments in IAM magazine on the Tasuku Honjo patent dispute
BRAND IDENTITY IS, NOW MORE THAN EVER, PARAMOUNT TO STAYING MEMORABLE
Client NewsOur client writes for Brands Journal on the importance of brand identity
Online Harms Bill Misses the Point
Client NewsOur client’s op-ed article in The Times yesterday morning details how the pending Online Harms Bill misses the point.
£18.4 MILLION MARRIOTT INTERNATIONAL GDPR FINE ANNOUNCED BY IPO: WHAT DID WE LEARN?
Client NewsOur client writes for Lawyer Monthly Magazine on what companies should learn from Marriott International’s £18.4 million GDPR fine
EU Commission sets out new intellectual property action plan affecting SEPs, patent pooling and EU design protection
Client NewsOur client’s article in Global Banking & Finance Review discusses the EU Commission’s new intellectual property action plan affecting SEPs, patent pooling and EU design protection
Trump trademark blow; Iancu speaks at ARIPO event; protecting clown faces
Client NewsOur client announces the expansion of its trademark capability with the appointment of Robin Richardson, bringing the trade mark team headcount to a record high of 13 across its UK offices. The appointment was covered across IP publications including World Trademark Review.
UK cartel enforcement – another false dawn?
Client NewsOur client writes for Fraud Intelligence looking at whether we can expect an upturn in the level of criminal investigation of cartel activity in light of the Memorandum of Understanding recently concluded between the SFO and the CMA
Priority and the ‘same applicant’ test: EPO maintains status quo
Client NewsOur client’s article in The Patent Lawyer provides an overview of the EPO Board of Appeal’s confirmation of its revocation of an important CRISPR patent (decision T 844/18)